ZA828546B - 2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1-piperazinyl)pyridines - Google Patents

2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1-piperazinyl)pyridines

Info

Publication number
ZA828546B
ZA828546B ZA828546A ZA828546A ZA828546B ZA 828546 B ZA828546 B ZA 828546B ZA 828546 A ZA828546 A ZA 828546A ZA 828546 A ZA828546 A ZA 828546A ZA 828546 B ZA828546 B ZA 828546B
Authority
ZA
South Africa
Prior art keywords
piperidinedion
pyridines
piperazinyl
dialkyl
butyl
Prior art date
Application number
ZA828546A
Other languages
English (en)
Inventor
Davis L Temple
Joseph P Yevich
Walter G Lobeck
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA828546B publication Critical patent/ZA828546B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA828546A 1981-12-28 1982-11-19 2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1-piperazinyl)pyridines ZA828546B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/334,689 US4361565A (en) 1981-12-28 1981-12-28 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Publications (1)

Publication Number Publication Date
ZA828546B true ZA828546B (en) 1983-09-28

Family

ID=23308356

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA828546A ZA828546B (en) 1981-12-28 1982-11-19 2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1-piperazinyl)pyridines

Country Status (27)

Country Link
US (1) US4361565A (es)
JP (1) JPS58118583A (es)
KR (1) KR880002011B1 (es)
AT (1) AT380880B (es)
AU (1) AU560667B2 (es)
BE (1) BE895505A (es)
CA (1) CA1237722A (es)
CH (1) CH653682A5 (es)
CY (1) CY1378A (es)
DE (1) DE3248138A1 (es)
DK (1) DK162284C (es)
ES (1) ES518511A0 (es)
FI (1) FI70892C (es)
FR (1) FR2518994B1 (es)
GB (1) GB2114121B (es)
GR (1) GR77101B (es)
HK (1) HK5188A (es)
HU (1) HU190827B (es)
IE (1) IE54620B1 (es)
IT (1) IT1158040B (es)
KE (1) KE3714A (es)
LU (1) LU84562A1 (es)
NL (1) NL8204974A (es)
PT (1) PT76037B (es)
SE (1) SE449748B (es)
SG (1) SG29687G (es)
ZA (1) ZA828546B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387221B (de) * 1980-09-08 1988-12-27 Bristol Myers Co Verfahren zur herstellung des neuen
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4757073A (en) * 1986-09-30 1988-07-12 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity
AU2717288A (en) * 1987-11-12 1989-06-01 American Home Products Corporation Polycyclicamines with psychotropic activity
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5098904A (en) * 1990-06-27 1992-03-24 Bristol-Myers Squibb Company Cerebral function enhancing pyrimidinyl derivatives
ES2084763T3 (es) * 1990-10-23 1996-05-16 Akzo Nobel Nv 4-(4- o 6-(2-trifluormetil piridinil))1-piperazinilalquilo lactamas sustituidas.
CA2097607A1 (en) * 1990-12-24 1992-06-24 Marcel Hibert Use of certain glutarimide derivatives in the treatment of depression and mania
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド グリコーゲンシンターゼキナーゼ3のインヒビター
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
PL2159226T3 (pl) * 2007-03-29 2017-02-28 Joint-Stock Company "Obninsk Chemical Pharmaceutical Company" Środek antyhistaminowy i antyalergiczny oraz sposób jego wytwarzania

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
FI791926A (fi) * 1978-06-20 1979-12-21 Synthelabo Fenylpiperazinderivat
US4305944A (en) * 1980-09-08 1981-12-15 Mead Johnson & Company N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones

Also Published As

Publication number Publication date
SE8207426D0 (sv) 1982-12-27
FI70892C (fi) 1986-10-27
SE8207426L (sv) 1983-06-29
FR2518994A1 (fr) 1983-07-01
GB2114121A (en) 1983-08-17
LU84562A1 (fr) 1983-09-08
SE449748B (sv) 1987-05-18
ES8402832A1 (es) 1984-03-01
IT8249720A0 (it) 1982-12-22
DK162284C (da) 1992-03-16
AU9108482A (en) 1983-07-07
GB2114121B (en) 1985-11-27
AT380880B (de) 1986-07-25
DK573282A (da) 1983-06-29
DE3248138C2 (es) 1992-12-10
JPS58118583A (ja) 1983-07-14
JPH0567637B2 (es) 1993-09-27
ES518511A0 (es) 1984-03-01
NL8204974A (nl) 1983-07-18
FR2518994B1 (fr) 1986-09-05
KE3714A (en) 1987-04-16
SG29687G (en) 1987-07-17
ATA467682A (de) 1985-12-15
DE3248138A1 (de) 1983-07-07
KR880002011B1 (ko) 1988-10-12
IE54620B1 (en) 1989-12-20
FI70892B (fi) 1986-07-18
IT1158040B (it) 1987-02-18
GR77101B (es) 1984-09-06
CH653682A5 (de) 1986-01-15
FI824443L (fi) 1983-06-29
CA1237722A (en) 1988-06-07
KR840002826A (ko) 1984-07-21
PT76037A (en) 1983-01-01
FI824443A0 (fi) 1982-12-23
BE895505A (fr) 1983-06-28
DK162284B (da) 1991-10-07
US4361565A (en) 1982-11-30
AU560667B2 (en) 1987-04-16
HK5188A (en) 1988-01-29
IE823068L (en) 1983-06-28
HU190827B (en) 1986-11-28
CY1378A (en) 1987-08-07
PT76037B (en) 1985-12-16

Similar Documents

Publication Publication Date Title
SG29787G (en) 2-(4-((4,4-diakyl-2, 6-piperidinedion-1-yl) butyl)-1-piperazinyl) pyrimidines
ZA828546B (en) 2-(4-((4,4-dialkyl-2,6-piperidinedion-1-yl)butyl)-1-piperazinyl)pyridines
DE3486121D1 (en) 4-((bicyclische heterocyclyl)methyl und -hetero)-piperidine.
DE3268733D1 (en) 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
AU556084B2 (en) 4-(2-fluoro-4-halo-5-substituted phenyl)-urazols
YU201285A (en) Process for obtaining new 2-(2[-nitrobenzoile)-1,3-cyclohexandione
JPS5791980A (en) 2,4-disubstituted thiazole derivatives
AU591740B2 (en) 2-((3,5-dihalo-4-aminobenzyl)) imidazolines
AU8793182A (en) Omega-(4-(2-pyridyl)-piperazino)alkanoylanilide derivatives
AU7097287A (en) 2-(4-mercaptoazetidin-2-on-1-yl) propenate derivatives
AU550614B2 (en) 2-phenyl-2-(pyridyloxy)-ethylamines
JPS56138170A (en) 2-(1-piperazinyl)-2,4,6-cycloheptatriene-1-one derivative
AU544794B2 (en) 4-(2,2-dialkyl-indane-1-ylidene)-piperidines
GB2078222B (en) 4-(3-iodopropargyloxy)pyrimidines
JPS56125384A (en) 2-(1-piperazinyl)cycloheptimidazole derivative
GB2159154B (en) Methyl 2-(2-hydroperoxy-2-propyl)naphthalene-6-carboxylate
ZA818900B (en) 1,4-disubstituted piperazine derivatives and process for the preparation thereof
YU240282A (en) Process for preparing 4-(3-methly-2-butenyl)1,2-diphenyl-3,5-dioxopyrazolidine
IE871642L (en) 4-(3'trifluoromethylphenoxy)-benzoylacetic acid derivatives.
AU540657B2 (en) 2-(1-piperazinyl)-2,4,6-cycloheptatriene-1-one derivative
GB2102417B (en) Micronised 2-(4-chlorophenyl)-s-triazolo]5,1-aisoquinolin
AU546666B2 (en) 4-(2,4-dichloro-3-methylbenzoyl)-1,3-dimethyl-5-phenacyloxy- pyrazoles
AU600073C (en) 2-(1,2,4-triazol-1-yl)methyl- tetrahydro-furans
PH17535A (en) 2-(4-hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
IE812090L (en) 2-(1, 4-benzodioxan-2-ylalkyl) imidazoles